1. What are drugs and why are they required?2. Drugs against gram-negative bacteria3. Drugs targeting gram-positive bacteria4. Drug repurposing against bacteria5. Drugs against M. tuberculosis6. Drugs against TB and Bioweapons7. New approaches to drug discovery: Peptides/quorum sensing/virulence8. New strategies and targets for antibacterial discovery9. Targeting efflux pumps for AMR10. Discovering antibiotics from Phages11. Drugs against non-tuberculous mycobacteria
Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at
Department of Pharmaceutical Sciences, Dr. Harisingh Gour
Vishwavidyalaya, Sagar, Madhya Pradesh, India. He has more than 12
years of teaching, research, and industrial experience at
international levels from various countries, including the United
States, Malaysia, and India. An overarching goal of his current
research is the development of nanoengineered drug delivery systems
for various diseases. He has more than 350 international
publications in well-reputed journals and more than 25
international books (Elsevier). He is a recipient of many research
grants from various funding bodies. He is also the recipient of
several internationally acclaimed awards, such as “USERN Laureate
award, most prestigious “SERB-Ramanujan Fellowship Award. He
actively participates in outreach and scientific dissemination for
the service of the wider community. His Number of citations is =
26779; h-index = 85; i-10 index = 370 (According to google scholar
on March 2025). He has more than 30 international publications
published in very high impact factor journals (Progress in Polymer
Sciences IF 32.063, Molecular Sciences IF 41.444, Progress in
Material Sciences IF 48.580, Advanced Materials IF 29.4, Drug
Resistance Update IF 22.841 and Material Todays IF 32.072). He has
presented many invited talks and oral presentations at prestigious
scientific peer-conferences, received international acclaims and
awards for research contribution, supervised students/junior
researchers and actively participated in outreach and scientific
dissemination for the service of the wider community.
Dr. Sidharth Chopra is a Senior Scientist, at Division of
Microbiology, CSIR-Central Drug Research Institute, Lucknow, India.
He has ~35 international publications in well reputed journals. One
of his article is published in Bioresource technology 77 (3),
215-227 with 999 citations and he has extensively worked on
discovery and development of NCE against ESKAPE, mycobacterial
infections as well as biothreat pathogens. Dr. Arunava Dasgupta a
Senior Scientist, at Division of Microbiology, CSIR-Central Drug
Research Institute, Lucknow, India. He has ~20 international
publications in well reputed journals. He has extensively worked on
discovery and development of NCE against mycobacterial infections
as well as understanding hostpathogen interaction.
"This book provides quality information and is a good educational tool." --Doody
|
Ask a Question About this Product More... |
|
